nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—AHR—Flutamide—prostate cancer	0.271	0.673	CbGbCtD
Nimodipine—AHR—prostate cancer	0.222	0.604	CbGaD
Nimodipine—CYP3A5—prostate cancer	0.102	0.276	CbGaD
Nimodipine—CYP3A4—prostate cancer	0.044	0.12	CbGaD
Nimodipine—CYP3A5—Flutamide—prostate cancer	0.017	0.0423	CbGbCtD
Nimodipine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0152	0.0379	CbGbCtD
Nimodipine—CYP3A5—Cabazitaxel—prostate cancer	0.0126	0.0313	CbGbCtD
Nimodipine—CYP3A5—Estrone—prostate cancer	0.0123	0.0306	CbGbCtD
Nimodipine—CYP3A4—Bicalutamide—prostate cancer	0.00801	0.0199	CbGbCtD
Nimodipine—CYP3A4—Estramustine—prostate cancer	0.00744	0.0185	CbGbCtD
Nimodipine—CYP3A5—Estradiol—prostate cancer	0.00707	0.0176	CbGbCtD
Nimodipine—CYP3A4—Flutamide—prostate cancer	0.00664	0.0165	CbGbCtD
Nimodipine—CYP3A4—Abiraterone—prostate cancer	0.00664	0.0165	CbGbCtD
Nimodipine—CYP3A4—Cabazitaxel—prostate cancer	0.00491	0.0122	CbGbCtD
Nimodipine—CYP3A4—Estrone—prostate cancer	0.0048	0.0119	CbGbCtD
Nimodipine—CYP3A5—Etoposide—prostate cancer	0.00461	0.0115	CbGbCtD
Nimodipine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00428	0.0106	CbGbCtD
Nimodipine—CYP3A5—Docetaxel—prostate cancer	0.00422	0.0105	CbGbCtD
Nimodipine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00314	0.0078	CbGbCtD
Nimodipine—CYP3A4—Mitoxantrone—prostate cancer	0.00285	0.00709	CbGbCtD
Nimodipine—CACNB4—prostate gland—prostate cancer	0.00276	0.0768	CbGeAlD
Nimodipine—CYP3A4—Estradiol—prostate cancer	0.00276	0.00685	CbGbCtD
Nimodipine—CYP3A4—Prednisone—prostate cancer	0.00237	0.00589	CbGbCtD
Nimodipine—CACNB1—prostate gland—prostate cancer	0.00221	0.0613	CbGeAlD
Nimodipine—CACNB3—prostate gland—prostate cancer	0.00212	0.0588	CbGeAlD
Nimodipine—CACNA1S—seminal vesicle—prostate cancer	0.002	0.0556	CbGeAlD
Nimodipine—CYP3A4—Etoposide—prostate cancer	0.0018	0.00447	CbGbCtD
Nimodipine—CACNB3—seminal vesicle—prostate cancer	0.00179	0.0497	CbGeAlD
Nimodipine—CYP3A4—Docetaxel—prostate cancer	0.00165	0.00409	CbGbCtD
Nimodipine—AHR—prostate gland—prostate cancer	0.00157	0.0436	CbGeAlD
Nimodipine—CACNB2—prostate gland—prostate cancer	0.00142	0.0395	CbGeAlD
Nimodipine—CACNB3—urethra—prostate cancer	0.00142	0.0394	CbGeAlD
Nimodipine—AHR—seminal vesicle—prostate cancer	0.00133	0.0368	CbGeAlD
Nimodipine—CACNA1D—prostate gland—prostate cancer	0.00124	0.0345	CbGeAlD
Nimodipine—CYP3A4—Doxorubicin—prostate cancer	0.00123	0.00305	CbGbCtD
Nimodipine—CACNB4—testis—prostate cancer	0.00122	0.0338	CbGeAlD
Nimodipine—CYP3A4—urine—prostate cancer	0.00118	0.0328	CbGeAlD
Nimodipine—CACNA1C—prostate gland—prostate cancer	0.00115	0.0319	CbGeAlD
Nimodipine—AHR—urethra—prostate cancer	0.00105	0.0292	CbGeAlD
Nimodipine—NR3C2—prostate gland—prostate cancer	0.00104	0.029	CbGeAlD
Nimodipine—CACNB1—testis—prostate cancer	0.000972	0.027	CbGeAlD
Nimodipine—CACNB3—testis—prostate cancer	0.000932	0.0259	CbGeAlD
Nimodipine—NR3C2—seminal vesicle—prostate cancer	0.000883	0.0245	CbGeAlD
Nimodipine—AHR—bone marrow—prostate cancer	0.000808	0.0224	CbGeAlD
Nimodipine—NR3C2—renal system—prostate cancer	0.000712	0.0198	CbGeAlD
Nimodipine—CACNB1—lymph node—prostate cancer	0.000704	0.0196	CbGeAlD
Nimodipine—NR3C2—urethra—prostate cancer	0.000699	0.0194	CbGeAlD
Nimodipine—AHR—testis—prostate cancer	0.000691	0.0192	CbGeAlD
Nimodipine—CACNB3—lymph node—prostate cancer	0.000676	0.0188	CbGeAlD
Nimodipine—CACNB2—testis—prostate cancer	0.000626	0.0174	CbGeAlD
Nimodipine—CYP3A5—prostate gland—prostate cancer	0.000564	0.0157	CbGeAlD
Nimodipine—CACNA1D—testis—prostate cancer	0.000547	0.0152	CbGeAlD
Nimodipine—CACNA1C—testis—prostate cancer	0.000505	0.014	CbGeAlD
Nimodipine—AHR—lymph node—prostate cancer	0.000501	0.0139	CbGeAlD
Nimodipine—NR3C2—testis—prostate cancer	0.00046	0.0128	CbGeAlD
Nimodipine—CACNB2—lymph node—prostate cancer	0.000454	0.0126	CbGeAlD
Nimodipine—CACNA1D—lymph node—prostate cancer	0.000397	0.011	CbGeAlD
Nimodipine—CYP3A5—renal system—prostate cancer	0.000385	0.0107	CbGeAlD
Nimodipine—CACNA1C—lymph node—prostate cancer	0.000366	0.0102	CbGeAlD
Nimodipine—NR3C2—lymph node—prostate cancer	0.000333	0.00926	CbGeAlD
Nimodipine—CYP3A4—renal system—prostate cancer	0.000289	0.00802	CbGeAlD
Nimodipine—Lercanidipine—CYP3A5—prostate cancer	0.000218	0.0733	CrCbGaD
Nimodipine—Nisoldipine—CYP3A5—prostate cancer	0.000166	0.0559	CrCbGaD
Nimodipine—Nitrendipine—CYP3A5—prostate cancer	0.000155	0.0523	CrCbGaD
Nimodipine—Nilvadipine—CYP2A6—prostate cancer	0.00015	0.0507	CrCbGaD
Nimodipine—Amlodipine—CYP3A5—prostate cancer	0.000134	0.0451	CrCbGaD
Nimodipine—Amlodipine—CYP2A6—prostate cancer	0.00013	0.0436	CrCbGaD
Nimodipine—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000126	0.00126	CcSEcCtD
Nimodipine—Felodipine—CYP3A5—prostate cancer	0.000124	0.0417	CrCbGaD
Nimodipine—Pruritus—Ethinyl Estradiol—prostate cancer	0.000123	0.00123	CcSEcCtD
Nimodipine—Palpitations—Estradiol—prostate cancer	0.000123	0.00122	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000122	0.00122	CcSEcCtD
Nimodipine—Nausea—Bicalutamide—prostate cancer	0.000122	0.00122	CcSEcCtD
Nimodipine—Fluid retention—Doxorubicin—prostate cancer	0.000121	0.00121	CcSEcCtD
Nimodipine—Sweating increased—Capecitabine—prostate cancer	0.000121	0.00121	CcSEcCtD
Nimodipine—Hypertension—Estradiol—prostate cancer	0.00012	0.0012	CcSEcCtD
Nimodipine—Nifedipine—CYP3A5—prostate cancer	0.00012	0.0403	CrCbGaD
Nimodipine—Anaemia—Mitoxantrone—prostate cancer	0.000119	0.00119	CcSEcCtD
Nimodipine—Clevidipine—CYP2E1—prostate cancer	0.000119	0.0401	CrCbGaD
Nimodipine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000119	0.00119	CcSEcCtD
Nimodipine—Myalgia—Estradiol—prostate cancer	0.000118	0.00118	CcSEcCtD
Nimodipine—Clevidipine—CYP2C19—prostate cancer	0.000118	0.0397	CrCbGaD
Nimodipine—Nicardipine—CYP3A5—prostate cancer	0.000118	0.0397	CrCbGaD
Nimodipine—Phlebitis—Epirubicin—prostate cancer	0.000116	0.00116	CcSEcCtD
Nimodipine—Nifedipine—CYP2A6—prostate cancer	0.000116	0.039	CrCbGaD
Nimodipine—Blood alkaline phosphatase increased—Epirubicin—prostate cancer	0.000115	0.00115	CcSEcCtD
Nimodipine—Dizziness—Ethinyl Estradiol—prostate cancer	0.000115	0.00115	CcSEcCtD
Nimodipine—Cardiac disorder—Etoposide—prostate cancer	0.000115	0.00114	CcSEcCtD
Nimodipine—Flushing—Etoposide—prostate cancer	0.000115	0.00114	CcSEcCtD
Nimodipine—Oedema—Estradiol—prostate cancer	0.000113	0.00113	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Prednisone—prostate cancer	0.000113	0.00113	CcSEcCtD
Nimodipine—Angiopathy—Etoposide—prostate cancer	0.000112	0.00112	CcSEcCtD
Nimodipine—Hypertension—Mitoxantrone—prostate cancer	0.000112	0.00111	CcSEcCtD
Nimodipine—Immune system disorder—Etoposide—prostate cancer	0.000112	0.00111	CcSEcCtD
Nimodipine—Jaundice—Docetaxel—prostate cancer	0.000111	0.00111	CcSEcCtD
Nimodipine—Nervous system disorder—Estradiol—prostate cancer	0.000111	0.00111	CcSEcCtD
Nimodipine—Tachycardia—Estradiol—prostate cancer	0.00011	0.0011	CcSEcCtD
Nimodipine—Depression—Capecitabine—prostate cancer	0.00011	0.0011	CcSEcCtD
Nimodipine—Cardiac failure congestive—Epirubicin—prostate cancer	0.00011	0.0011	CcSEcCtD
Nimodipine—Vomiting—Ethinyl Estradiol—prostate cancer	0.00011	0.0011	CcSEcCtD
Nimodipine—Myalgia—Mitoxantrone—prostate cancer	0.00011	0.0011	CcSEcCtD
Nimodipine—Hyperhidrosis—Estradiol—prostate cancer	0.000109	0.00109	CcSEcCtD
Nimodipine—Rash—Ethinyl Estradiol—prostate cancer	0.000109	0.00109	CcSEcCtD
Nimodipine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000109	0.00109	CcSEcCtD
Nimodipine—Headache—Ethinyl Estradiol—prostate cancer	0.000109	0.00109	CcSEcCtD
Nimodipine—Hepatobiliary disease—Docetaxel—prostate cancer	0.000108	0.00108	CcSEcCtD
Nimodipine—Jaundice—Capecitabine—prostate cancer	0.000108	0.00108	CcSEcCtD
Nimodipine—Sweating increased—Prednisone—prostate cancer	0.000108	0.00108	CcSEcCtD
Nimodipine—Phlebitis—Doxorubicin—prostate cancer	0.000107	0.00107	CcSEcCtD
Nimodipine—Nilvadipine—CYP2E1—prostate cancer	0.000107	0.036	CrCbGaD
Nimodipine—Blood alkaline phosphatase increased—Doxorubicin—prostate cancer	0.000106	0.00106	CcSEcCtD
Nimodipine—Nilvadipine—CYP2C19—prostate cancer	0.000106	0.0356	CrCbGaD
Nimodipine—Oedema—Mitoxantrone—prostate cancer	0.000105	0.00105	CcSEcCtD
Nimodipine—Hypersensitivity—Goserelin—prostate cancer	0.000105	0.00105	CcSEcCtD
Nimodipine—Hepatobiliary disease—Capecitabine—prostate cancer	0.000105	0.00105	CcSEcCtD
Nimodipine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000104	0.00104	CcSEcCtD
Nimodipine—Muscle spasms—Etoposide—prostate cancer	0.000103	0.00103	CcSEcCtD
Nimodipine—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000103	0.00103	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000103	0.00103	CcSEcCtD
Nimodipine—Nausea—Ethinyl Estradiol—prostate cancer	0.000103	0.00103	CcSEcCtD
Nimodipine—Tachycardia—Mitoxantrone—prostate cancer	0.000103	0.00103	CcSEcCtD
Nimodipine—Hepatitis—Docetaxel—prostate cancer	0.000103	0.00103	CcSEcCtD
Nimodipine—Cardiac failure congestive—Doxorubicin—prostate cancer	0.000102	0.00102	CcSEcCtD
Nimodipine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000102	0.00102	CcSEcCtD
Nimodipine—Bradycardia—Capecitabine—prostate cancer	0.000101	0.00101	CcSEcCtD
Nimodipine—Pruritus—Goserelin—prostate cancer	0.000101	0.00101	CcSEcCtD
Nimodipine—Dyspnoea—Estradiol—prostate cancer	0.000101	0.00101	CcSEcCtD
Nimodipine—Hyponatraemia—Epirubicin—prostate cancer	0.0001	0.001	CcSEcCtD
Nimodipine—Pruritus—Conjugated Estrogens—prostate cancer	0.0001	0.001	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	0.0001	0.001	CcSEcCtD
Nimodipine—Hepatitis—Capecitabine—prostate cancer	9.93e-05	0.000993	CcSEcCtD
Nimodipine—Anaemia—Etoposide—prostate cancer	9.93e-05	0.000993	CcSEcCtD
Nimodipine—Hypotension—Mitoxantrone—prostate cancer	9.85e-05	0.000985	CcSEcCtD
Nimodipine—Depression—Prednisone—prostate cancer	9.83e-05	0.000982	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Estradiol—prostate cancer	9.77e-05	0.000976	CcSEcCtD
Nimodipine—Diarrhoea—Goserelin—prostate cancer	9.77e-05	0.000976	CcSEcCtD
Nimodipine—Diarrhoea—Conjugated Estrogens—prostate cancer	9.67e-05	0.000967	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	9.61e-05	0.00096	CcSEcCtD
Nimodipine—Cardiac disorder—Docetaxel—prostate cancer	9.52e-05	0.000952	CcSEcCtD
Nimodipine—Flushing—Docetaxel—prostate cancer	9.52e-05	0.000952	CcSEcCtD
Nimodipine—Dizziness—Goserelin—prostate cancer	9.44e-05	0.000943	CcSEcCtD
Nimodipine—Lercanidipine—CYP3A4—prostate cancer	9.42e-05	0.0317	CrCbGaD
Nimodipine—Dyspnoea—Mitoxantrone—prostate cancer	9.4e-05	0.000939	CcSEcCtD
Nimodipine—Dizziness—Conjugated Estrogens—prostate cancer	9.35e-05	0.000934	CcSEcCtD
Nimodipine—Angiopathy—Docetaxel—prostate cancer	9.31e-05	0.00093	CcSEcCtD
Nimodipine—Hyponatraemia—Doxorubicin—prostate cancer	9.29e-05	0.000929	CcSEcCtD
Nimodipine—Hypertension—Etoposide—prostate cancer	9.28e-05	0.000927	CcSEcCtD
Nimodipine—Immune system disorder—Docetaxel—prostate cancer	9.27e-05	0.000926	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	9.26e-05	0.000925	CcSEcCtD
Nimodipine—Liver function test abnormal—Epirubicin—prostate cancer	9.23e-05	0.000923	CcSEcCtD
Nimodipine—Cardiac disorder—Capecitabine—prostate cancer	9.22e-05	0.000921	CcSEcCtD
Nimodipine—Flushing—Capecitabine—prostate cancer	9.22e-05	0.000921	CcSEcCtD
Nimodipine—Vomiting—Goserelin—prostate cancer	9.08e-05	0.000907	CcSEcCtD
Nimodipine—Amlodipine—CYP1A1—prostate cancer	9.08e-05	0.0306	CrCbGaD
Nimodipine—Angiopathy—Capecitabine—prostate cancer	9.01e-05	0.000901	CcSEcCtD
Nimodipine—Bradycardia—Prednisone—prostate cancer	9.01e-05	0.0009	CcSEcCtD
Nimodipine—Rash—Goserelin—prostate cancer	9e-05	0.000899	CcSEcCtD
Nimodipine—Dermatitis—Goserelin—prostate cancer	8.99e-05	0.000899	CcSEcCtD
Nimodipine—Vomiting—Conjugated Estrogens—prostate cancer	8.99e-05	0.000898	CcSEcCtD
Nimodipine—Immune system disorder—Capecitabine—prostate cancer	8.97e-05	0.000897	CcSEcCtD
Nimodipine—Headache—Goserelin—prostate cancer	8.94e-05	0.000894	CcSEcCtD
Nimodipine—Rash—Conjugated Estrogens—prostate cancer	8.91e-05	0.000891	CcSEcCtD
Nimodipine—Dermatitis—Conjugated Estrogens—prostate cancer	8.91e-05	0.00089	CcSEcCtD
Nimodipine—Headache—Conjugated Estrogens—prostate cancer	8.86e-05	0.000885	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Epirubicin—prostate cancer	8.82e-05	0.000882	CcSEcCtD
Nimodipine—Thrombocytopenia—Etoposide—prostate cancer	8.59e-05	0.000858	CcSEcCtD
Nimodipine—Muscle spasms—Docetaxel—prostate cancer	8.59e-05	0.000858	CcSEcCtD
Nimodipine—Tachycardia—Etoposide—prostate cancer	8.56e-05	0.000855	CcSEcCtD
Nimodipine—Liver function test abnormal—Doxorubicin—prostate cancer	8.54e-05	0.000854	CcSEcCtD
Nimodipine—Isradipine—CYP3A4—prostate cancer	8.52e-05	0.0287	CrCbGaD
Nimodipine—Nausea—Goserelin—prostate cancer	8.48e-05	0.000847	CcSEcCtD
Nimodipine—Hyperhidrosis—Etoposide—prostate cancer	8.48e-05	0.000847	CcSEcCtD
Nimodipine—Nausea—Conjugated Estrogens—prostate cancer	8.4e-05	0.000839	CcSEcCtD
Nimodipine—Hypersensitivity—Estradiol—prostate cancer	8.34e-05	0.000833	CcSEcCtD
Nimodipine—Muscle spasms—Capecitabine—prostate cancer	8.31e-05	0.000831	CcSEcCtD
Nimodipine—Anaemia—Docetaxel—prostate cancer	8.25e-05	0.000825	CcSEcCtD
Nimodipine—Nifedipine—CYP2E1—prostate cancer	8.23e-05	0.0277	CrCbGaD
Nimodipine—Flushing—Prednisone—prostate cancer	8.21e-05	0.000821	CcSEcCtD
Nimodipine—Hypotension—Etoposide—prostate cancer	8.2e-05	0.000819	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Doxorubicin—prostate cancer	8.16e-05	0.000816	CcSEcCtD
Nimodipine—Nifedipine—CYP1A1—prostate cancer	8.11e-05	0.0273	CrCbGaD
Nimodipine—Nicardipine—CYP2E1—prostate cancer	8.1e-05	0.0273	CrCbGaD
Nimodipine—Angiopathy—Prednisone—prostate cancer	8.03e-05	0.000802	CcSEcCtD
Nimodipine—Nicardipine—CYP2C19—prostate cancer	8.02e-05	0.027	CrCbGaD
Nimodipine—Pruritus—Estradiol—prostate cancer	8.01e-05	0.0008	CcSEcCtD
Nimodipine—Anaemia—Capecitabine—prostate cancer	7.99e-05	0.000799	CcSEcCtD
Nimodipine—Immune system disorder—Prednisone—prostate cancer	7.99e-05	0.000799	CcSEcCtD
Nimodipine—Palpitations—Docetaxel—prostate cancer	7.89e-05	0.000789	CcSEcCtD
Nimodipine—Dyspnoea—Etoposide—prostate cancer	7.82e-05	0.000781	CcSEcCtD
Nimodipine—Hypersensitivity—Mitoxantrone—prostate cancer	7.77e-05	0.000776	CcSEcCtD
Nimodipine—Diarrhoea—Estradiol—prostate cancer	7.74e-05	0.000774	CcSEcCtD
Nimodipine—Hypertension—Docetaxel—prostate cancer	7.71e-05	0.000771	CcSEcCtD
Nimodipine—Palpitations—Capecitabine—prostate cancer	7.64e-05	0.000764	CcSEcCtD
Nimodipine—Myalgia—Docetaxel—prostate cancer	7.6e-05	0.00076	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Etoposide—prostate cancer	7.57e-05	0.000757	CcSEcCtD
Nimodipine—Jaundice—Epirubicin—prostate cancer	7.51e-05	0.000751	CcSEcCtD
Nimodipine—Clevidipine—CYP3A4—prostate cancer	7.5e-05	0.0253	CrCbGaD
Nimodipine—Dizziness—Estradiol—prostate cancer	7.48e-05	0.000748	CcSEcCtD
Nimodipine—Hypertension—Capecitabine—prostate cancer	7.47e-05	0.000746	CcSEcCtD
Nimodipine—Myalgia—Capecitabine—prostate cancer	7.36e-05	0.000736	CcSEcCtD
Nimodipine—Hepatobiliary disease—Epirubicin—prostate cancer	7.29e-05	0.000729	CcSEcCtD
Nimodipine—Oedema—Docetaxel—prostate cancer	7.29e-05	0.000728	CcSEcCtD
Nimodipine—Diarrhoea—Mitoxantrone—prostate cancer	7.21e-05	0.000721	CcSEcCtD
Nimodipine—Vomiting—Estradiol—prostate cancer	7.19e-05	0.000719	CcSEcCtD
Nimodipine—Nisoldipine—CYP3A4—prostate cancer	7.19e-05	0.0242	CrCbGaD
Nimodipine—Nervous system disorder—Docetaxel—prostate cancer	7.15e-05	0.000714	CcSEcCtD
Nimodipine—Thrombocytopenia—Docetaxel—prostate cancer	7.14e-05	0.000713	CcSEcCtD
Nimodipine—Rash—Estradiol—prostate cancer	7.13e-05	0.000713	CcSEcCtD
Nimodipine—Dermatitis—Estradiol—prostate cancer	7.13e-05	0.000712	CcSEcCtD
Nimodipine—Anaemia—Prednisone—prostate cancer	7.12e-05	0.000711	CcSEcCtD
Nimodipine—Tachycardia—Docetaxel—prostate cancer	7.11e-05	0.000711	CcSEcCtD
Nimodipine—Headache—Estradiol—prostate cancer	7.09e-05	0.000708	CcSEcCtD
Nimodipine—Oedema—Capecitabine—prostate cancer	7.06e-05	0.000705	CcSEcCtD
Nimodipine—Bradycardia—Epirubicin—prostate cancer	7.04e-05	0.000704	CcSEcCtD
Nimodipine—Jaundice—Doxorubicin—prostate cancer	6.95e-05	0.000695	CcSEcCtD
Nimodipine—Nervous system disorder—Capecitabine—prostate cancer	6.92e-05	0.000692	CcSEcCtD
Nimodipine—Hepatitis—Epirubicin—prostate cancer	6.92e-05	0.000692	CcSEcCtD
Nimodipine—Thrombocytopenia—Capecitabine—prostate cancer	6.91e-05	0.000691	CcSEcCtD
Nimodipine—Tachycardia—Capecitabine—prostate cancer	6.89e-05	0.000688	CcSEcCtD
Nimodipine—Hyperhidrosis—Capecitabine—prostate cancer	6.82e-05	0.000682	CcSEcCtD
Nimodipine—Hypotension—Docetaxel—prostate cancer	6.81e-05	0.000681	CcSEcCtD
Nimodipine—Hepatobiliary disease—Doxorubicin—prostate cancer	6.75e-05	0.000674	CcSEcCtD
Nimodipine—Nitrendipine—CYP3A4—prostate cancer	6.73e-05	0.0227	CrCbGaD
Nimodipine—Nilvadipine—CYP3A4—prostate cancer	6.73e-05	0.0227	CrCbGaD
Nimodipine—Nausea—Estradiol—prostate cancer	6.72e-05	0.000672	CcSEcCtD
Nimodipine—Vomiting—Mitoxantrone—prostate cancer	6.7e-05	0.00067	CcSEcCtD
Nimodipine—Hypertension—Prednisone—prostate cancer	6.65e-05	0.000665	CcSEcCtD
Nimodipine—Rash—Mitoxantrone—prostate cancer	6.65e-05	0.000664	CcSEcCtD
Nimodipine—Dermatitis—Mitoxantrone—prostate cancer	6.64e-05	0.000664	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Docetaxel—prostate cancer	6.64e-05	0.000664	CcSEcCtD
Nimodipine—Headache—Mitoxantrone—prostate cancer	6.61e-05	0.00066	CcSEcCtD
Nimodipine—Hypotension—Capecitabine—prostate cancer	6.59e-05	0.000659	CcSEcCtD
Nimodipine—Myalgia—Prednisone—prostate cancer	6.56e-05	0.000655	CcSEcCtD
Nimodipine—Bradycardia—Doxorubicin—prostate cancer	6.52e-05	0.000651	CcSEcCtD
Nimodipine—Dyspnoea—Docetaxel—prostate cancer	6.5e-05	0.000649	CcSEcCtD
Nimodipine—Hypersensitivity—Etoposide—prostate cancer	6.46e-05	0.000646	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Capecitabine—prostate cancer	6.43e-05	0.000643	CcSEcCtD
Nimodipine—Cardiac disorder—Epirubicin—prostate cancer	6.42e-05	0.000642	CcSEcCtD
Nimodipine—Flushing—Epirubicin—prostate cancer	6.42e-05	0.000642	CcSEcCtD
Nimodipine—Hepatitis—Doxorubicin—prostate cancer	6.4e-05	0.00064	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Docetaxel—prostate cancer	6.29e-05	0.000629	CcSEcCtD
Nimodipine—Dyspnoea—Capecitabine—prostate cancer	6.29e-05	0.000629	CcSEcCtD
Nimodipine—Oedema—Prednisone—prostate cancer	6.29e-05	0.000628	CcSEcCtD
Nimodipine—Angiopathy—Epirubicin—prostate cancer	6.28e-05	0.000627	CcSEcCtD
Nimodipine—Nausea—Mitoxantrone—prostate cancer	6.26e-05	0.000626	CcSEcCtD
Nimodipine—Immune system disorder—Epirubicin—prostate cancer	6.25e-05	0.000625	CcSEcCtD
Nimodipine—Pruritus—Etoposide—prostate cancer	6.2e-05	0.00062	CcSEcCtD
Nimodipine—Nervous system disorder—Prednisone—prostate cancer	6.16e-05	0.000616	CcSEcCtD
Nimodipine—Tachycardia—Prednisone—prostate cancer	6.13e-05	0.000613	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Capecitabine—prostate cancer	6.09e-05	0.000609	CcSEcCtD
Nimodipine—Hyperhidrosis—Prednisone—prostate cancer	6.08e-05	0.000607	CcSEcCtD
Nimodipine—Diarrhoea—Etoposide—prostate cancer	6e-05	0.0006	CcSEcCtD
Nimodipine—Cardiac disorder—Doxorubicin—prostate cancer	5.94e-05	0.000594	CcSEcCtD
Nimodipine—Flushing—Doxorubicin—prostate cancer	5.94e-05	0.000594	CcSEcCtD
Nimodipine—Angiopathy—Doxorubicin—prostate cancer	5.81e-05	0.000581	CcSEcCtD
Nimodipine—Dizziness—Etoposide—prostate cancer	5.8e-05	0.00058	CcSEcCtD
Nimodipine—Amlodipine—CYP3A4—prostate cancer	5.79e-05	0.0195	CrCbGaD
Nimodipine—Muscle spasms—Epirubicin—prostate cancer	5.79e-05	0.000579	CcSEcCtD
Nimodipine—Immune system disorder—Doxorubicin—prostate cancer	5.78e-05	0.000578	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Prednisone—prostate cancer	5.73e-05	0.000572	CcSEcCtD
Nimodipine—Vomiting—Etoposide—prostate cancer	5.58e-05	0.000557	CcSEcCtD
Nimodipine—Anaemia—Epirubicin—prostate cancer	5.57e-05	0.000556	CcSEcCtD
Nimodipine—Rash—Etoposide—prostate cancer	5.53e-05	0.000553	CcSEcCtD
Nimodipine—Dermatitis—Etoposide—prostate cancer	5.52e-05	0.000552	CcSEcCtD
Nimodipine—Headache—Etoposide—prostate cancer	5.49e-05	0.000549	CcSEcCtD
Nimodipine—Hypersensitivity—Docetaxel—prostate cancer	5.37e-05	0.000537	CcSEcCtD
Nimodipine—Muscle spasms—Doxorubicin—prostate cancer	5.36e-05	0.000536	CcSEcCtD
Nimodipine—Felodipine—CYP3A4—prostate cancer	5.36e-05	0.018	CrCbGaD
Nimodipine—Palpitations—Epirubicin—prostate cancer	5.32e-05	0.000532	CcSEcCtD
Nimodipine—Nausea—Etoposide—prostate cancer	5.21e-05	0.000521	CcSEcCtD
Nimodipine—Hypertension—Epirubicin—prostate cancer	5.2e-05	0.00052	CcSEcCtD
Nimodipine—Hypersensitivity—Capecitabine—prostate cancer	5.2e-05	0.00052	CcSEcCtD
Nimodipine—Nifedipine—CYP3A4—prostate cancer	5.18e-05	0.0174	CrCbGaD
Nimodipine—Pruritus—Docetaxel—prostate cancer	5.16e-05	0.000515	CcSEcCtD
Nimodipine—Anaemia—Doxorubicin—prostate cancer	5.15e-05	0.000515	CcSEcCtD
Nimodipine—Myalgia—Epirubicin—prostate cancer	5.13e-05	0.000513	CcSEcCtD
Nimodipine—Nicardipine—CYP3A4—prostate cancer	5.1e-05	0.0172	CrCbGaD
Nimodipine—Pruritus—Capecitabine—prostate cancer	4.99e-05	0.000499	CcSEcCtD
Nimodipine—Diarrhoea—Docetaxel—prostate cancer	4.99e-05	0.000498	CcSEcCtD
Nimodipine—Palpitations—Doxorubicin—prostate cancer	4.93e-05	0.000492	CcSEcCtD
Nimodipine—Oedema—Epirubicin—prostate cancer	4.92e-05	0.000491	CcSEcCtD
Nimodipine—Diarrhoea—Capecitabine—prostate cancer	4.83e-05	0.000483	CcSEcCtD
Nimodipine—Nervous system disorder—Epirubicin—prostate cancer	4.82e-05	0.000482	CcSEcCtD
Nimodipine—Dizziness—Docetaxel—prostate cancer	4.82e-05	0.000482	CcSEcCtD
Nimodipine—Thrombocytopenia—Epirubicin—prostate cancer	4.81e-05	0.000481	CcSEcCtD
Nimodipine—Hypertension—Doxorubicin—prostate cancer	4.81e-05	0.000481	CcSEcCtD
Nimodipine—Tachycardia—Epirubicin—prostate cancer	4.8e-05	0.00048	CcSEcCtD
Nimodipine—Hyperhidrosis—Epirubicin—prostate cancer	4.75e-05	0.000475	CcSEcCtD
Nimodipine—Myalgia—Doxorubicin—prostate cancer	4.75e-05	0.000474	CcSEcCtD
Nimodipine—Dizziness—Capecitabine—prostate cancer	4.67e-05	0.000466	CcSEcCtD
Nimodipine—Vomiting—Docetaxel—prostate cancer	4.63e-05	0.000463	CcSEcCtD
Nimodipine—Hypersensitivity—Prednisone—prostate cancer	4.63e-05	0.000463	CcSEcCtD
Nimodipine—Rash—Docetaxel—prostate cancer	4.6e-05	0.000459	CcSEcCtD
Nimodipine—Hypotension—Epirubicin—prostate cancer	4.59e-05	0.000459	CcSEcCtD
Nimodipine—Dermatitis—Docetaxel—prostate cancer	4.59e-05	0.000459	CcSEcCtD
Nimodipine—Headache—Docetaxel—prostate cancer	4.57e-05	0.000456	CcSEcCtD
Nimodipine—Oedema—Doxorubicin—prostate cancer	4.55e-05	0.000455	CcSEcCtD
Nimodipine—Vomiting—Capecitabine—prostate cancer	4.49e-05	0.000448	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Epirubicin—prostate cancer	4.48e-05	0.000448	CcSEcCtD
Nimodipine—Nervous system disorder—Doxorubicin—prostate cancer	4.46e-05	0.000446	CcSEcCtD
Nimodipine—Thrombocytopenia—Doxorubicin—prostate cancer	4.45e-05	0.000445	CcSEcCtD
Nimodipine—Rash—Capecitabine—prostate cancer	4.45e-05	0.000445	CcSEcCtD
Nimodipine—Pruritus—Prednisone—prostate cancer	4.45e-05	0.000444	CcSEcCtD
Nimodipine—Dermatitis—Capecitabine—prostate cancer	4.45e-05	0.000444	CcSEcCtD
Nimodipine—Tachycardia—Doxorubicin—prostate cancer	4.44e-05	0.000444	CcSEcCtD
Nimodipine—Headache—Capecitabine—prostate cancer	4.42e-05	0.000442	CcSEcCtD
Nimodipine—Hyperhidrosis—Doxorubicin—prostate cancer	4.4e-05	0.000439	CcSEcCtD
Nimodipine—Dyspnoea—Epirubicin—prostate cancer	4.38e-05	0.000438	CcSEcCtD
Nimodipine—Nausea—Docetaxel—prostate cancer	4.33e-05	0.000433	CcSEcCtD
Nimodipine—Diarrhoea—Prednisone—prostate cancer	4.3e-05	0.00043	CcSEcCtD
Nimodipine—Hypotension—Doxorubicin—prostate cancer	4.25e-05	0.000425	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Epirubicin—prostate cancer	4.24e-05	0.000424	CcSEcCtD
Nimodipine—Nausea—Capecitabine—prostate cancer	4.19e-05	0.000419	CcSEcCtD
Nimodipine—Dizziness—Prednisone—prostate cancer	4.16e-05	0.000415	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.14e-05	0.000414	CcSEcCtD
Nimodipine—Dyspnoea—Doxorubicin—prostate cancer	4.06e-05	0.000405	CcSEcCtD
Nimodipine—Vomiting—Prednisone—prostate cancer	4e-05	0.000399	CcSEcCtD
Nimodipine—Rash—Prednisone—prostate cancer	3.96e-05	0.000396	CcSEcCtD
Nimodipine—Dermatitis—Prednisone—prostate cancer	3.96e-05	0.000396	CcSEcCtD
Nimodipine—Headache—Prednisone—prostate cancer	3.94e-05	0.000394	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.93e-05	0.000392	CcSEcCtD
Nimodipine—Nausea—Prednisone—prostate cancer	3.73e-05	0.000373	CcSEcCtD
Nimodipine—Hypersensitivity—Epirubicin—prostate cancer	3.62e-05	0.000362	CcSEcCtD
Nimodipine—Pruritus—Epirubicin—prostate cancer	3.48e-05	0.000348	CcSEcCtD
Nimodipine—Diarrhoea—Epirubicin—prostate cancer	3.36e-05	0.000336	CcSEcCtD
Nimodipine—Hypersensitivity—Doxorubicin—prostate cancer	3.35e-05	0.000335	CcSEcCtD
Nimodipine—Dizziness—Epirubicin—prostate cancer	3.25e-05	0.000325	CcSEcCtD
Nimodipine—Pruritus—Doxorubicin—prostate cancer	3.22e-05	0.000322	CcSEcCtD
Nimodipine—Vomiting—Epirubicin—prostate cancer	3.13e-05	0.000312	CcSEcCtD
Nimodipine—Diarrhoea—Doxorubicin—prostate cancer	3.11e-05	0.000311	CcSEcCtD
Nimodipine—Rash—Epirubicin—prostate cancer	3.1e-05	0.00031	CcSEcCtD
Nimodipine—Dermatitis—Epirubicin—prostate cancer	3.1e-05	0.000309	CcSEcCtD
Nimodipine—Headache—Epirubicin—prostate cancer	3.08e-05	0.000308	CcSEcCtD
Nimodipine—Dizziness—Doxorubicin—prostate cancer	3.01e-05	0.000301	CcSEcCtD
Nimodipine—Nausea—Epirubicin—prostate cancer	2.92e-05	0.000292	CcSEcCtD
Nimodipine—Vomiting—Doxorubicin—prostate cancer	2.89e-05	0.000289	CcSEcCtD
Nimodipine—Rash—Doxorubicin—prostate cancer	2.87e-05	0.000287	CcSEcCtD
Nimodipine—Dermatitis—Doxorubicin—prostate cancer	2.87e-05	0.000286	CcSEcCtD
Nimodipine—Headache—Doxorubicin—prostate cancer	2.85e-05	0.000285	CcSEcCtD
Nimodipine—Nausea—Doxorubicin—prostate cancer	2.7e-05	0.00027	CcSEcCtD
Nimodipine—CACNA1C—Metabolism—RXRA—prostate cancer	5.8e-06	6.39e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ARG2—prostate cancer	5.79e-06	6.39e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—UMPS—prostate cancer	5.79e-06	6.39e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PHGDH—prostate cancer	5.79e-06	6.39e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ERCC2—prostate cancer	5.77e-06	6.36e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HAO1—prostate cancer	5.75e-06	6.34e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	5.75e-06	6.34e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CB—prostate cancer	5.72e-06	6.3e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—LPL—prostate cancer	5.71e-06	6.29e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—prostate cancer	5.7e-06	6.29e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—LDHB—prostate cancer	5.68e-06	6.26e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—prostate cancer	5.67e-06	6.25e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—STAT3—prostate cancer	5.65e-06	6.23e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—COMT—prostate cancer	5.59e-06	6.16e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTP1—prostate cancer	5.56e-06	6.13e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6—prostate cancer	5.53e-06	6.1e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6—prostate cancer	5.53e-06	6.09e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KRAS—prostate cancer	5.52e-06	6.08e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP1A1—prostate cancer	5.51e-06	6.08e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ITPR1—prostate cancer	5.47e-06	6.03e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ERCC2—prostate cancer	5.47e-06	6.03e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—MTHFR—prostate cancer	5.43e-06	5.98e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PDHA1—prostate cancer	5.38e-06	5.94e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—UCP3—prostate cancer	5.38e-06	5.94e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TCN2—prostate cancer	5.38e-06	5.94e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTA3—prostate cancer	5.38e-06	5.94e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPARA—prostate cancer	5.32e-06	5.87e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TGFB1—prostate cancer	5.24e-06	5.77e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TYMS—prostate cancer	5.17e-06	5.7e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—MTHFR—prostate cancer	5.14e-06	5.67e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC22A3—prostate cancer	5.14e-06	5.66e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HSD3B1—prostate cancer	5.14e-06	5.66e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—prostate cancer	5.13e-06	5.66e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTM1—prostate cancer	5.11e-06	5.63e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT1—prostate cancer	5.1e-06	5.62e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPARA—prostate cancer	5.04e-06	5.56e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—LPL—prostate cancer	5.01e-06	5.53e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CAV1—prostate cancer	5e-06	5.52e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTEN—prostate cancer	4.94e-06	5.45e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTA4—prostate cancer	4.93e-06	5.43e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TBXAS1—prostate cancer	4.93e-06	5.43e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KRAS—prostate cancer	4.85e-06	5.35e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP1A1—prostate cancer	4.84e-06	5.34e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ERCC2—prostate cancer	4.8e-06	5.3e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTA2—prostate cancer	4.8e-06	5.29e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6—prostate cancer	4.74e-06	5.23e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—prostate cancer	4.74e-06	5.23e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SULT1A1—prostate cancer	4.74e-06	5.23e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCG5—prostate cancer	4.74e-06	5.23e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CAV1—prostate cancer	4.74e-06	5.23e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—EP300—prostate cancer	4.71e-06	5.2e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TST—prostate cancer	4.69e-06	5.17e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CBR1—prostate cancer	4.69e-06	5.17e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ADI1—prostate cancer	4.69e-06	5.17e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CSAD—prostate cancer	4.69e-06	5.17e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PSAT1—prostate cancer	4.69e-06	5.17e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GRHL1—prostate cancer	4.69e-06	5.17e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTA1—prostate cancer	4.63e-06	5.11e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HSD3B2—prostate cancer	4.58e-06	5.05e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTO1—prostate cancer	4.58e-06	5.05e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NAT2—prostate cancer	4.58e-06	5.05e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CG—prostate cancer	4.56e-06	5.03e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—MTHFR—prostate cancer	4.51e-06	4.98e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6—prostate cancer	4.49e-06	4.95e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPARA—prostate cancer	4.43e-06	4.88e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PLCB2—prostate cancer	4.39e-06	4.84e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—LRP2—prostate cancer	4.39e-06	4.84e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP2C18—prostate cancer	4.39e-06	4.84e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT1—prostate cancer	4.37e-06	4.82e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CKMT2—prostate cancer	4.36e-06	4.81e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GRHPR—prostate cancer	4.36e-06	4.81e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—UGT2B17—prostate cancer	4.36e-06	4.81e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—UGT2B15—prostate cancer	4.36e-06	4.81e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CG—prostate cancer	4.32e-06	4.76e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—INS—prostate cancer	4.32e-06	4.76e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—P4HB—prostate cancer	4.3e-06	4.75e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CREBBP—prostate cancer	4.23e-06	4.66e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC22A1—prostate cancer	4.19e-06	4.62e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CAV1—prostate cancer	4.16e-06	4.59e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT1—prostate cancer	4.14e-06	4.57e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SULT2B1—prostate cancer	4.1e-06	4.52e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AOX1—prostate cancer	4.1e-06	4.52e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTM3—prostate cancer	4.1e-06	4.52e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NAGLU—prostate cancer	4.1e-06	4.52e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MBTPS1—prostate cancer	4.1e-06	4.52e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—RFK—prostate cancer	4.1e-06	4.52e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PGAM2—prostate cancer	4.1e-06	4.52e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—INS—prostate cancer	4.09e-06	4.51e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SULT2A1—prostate cancer	4.08e-06	4.5e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MED12—prostate cancer	4.01e-06	4.43e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CD—prostate cancer	4.01e-06	4.42e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CREBBP—prostate cancer	4e-06	4.41e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GNG5—prostate cancer	3.98e-06	4.39e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6—prostate cancer	3.95e-06	4.35e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—DEGS1—prostate cancer	3.88e-06	4.28e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SRD5A2—prostate cancer	3.88e-06	4.28e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NAT1—prostate cancer	3.88e-06	4.28e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AMACR—prostate cancer	3.88e-06	4.28e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP3A43—prostate cancer	3.88e-06	4.28e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOA3—prostate cancer	3.84e-06	4.23e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CD—prostate cancer	3.8e-06	4.18e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CG—prostate cancer	3.79e-06	4.18e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NOS3—prostate cancer	3.78e-06	4.17e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HSD17B1—prostate cancer	3.71e-06	4.09e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HPGDS—prostate cancer	3.66e-06	4.04e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT1—prostate cancer	3.64e-06	4.01e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP2C19—prostate cancer	3.64e-06	4.01e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—INS—prostate cancer	3.59e-06	3.96e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NOS3—prostate cancer	3.58e-06	3.95e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ACHE—prostate cancer	3.55e-06	3.91e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTT1—prostate cancer	3.55e-06	3.91e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CREBBP—prostate cancer	3.52e-06	3.88e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP2A6—prostate cancer	3.51e-06	3.87e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CB—prostate cancer	3.49e-06	3.85e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CA—prostate cancer	3.49e-06	3.84e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—prostate cancer	3.46e-06	3.82e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKR1C3—prostate cancer	3.41e-06	3.76e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PRKACB—prostate cancer	3.4e-06	3.74e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP17A1—prostate cancer	3.36e-06	3.71e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CD—prostate cancer	3.33e-06	3.68e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CB—prostate cancer	3.31e-06	3.65e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—B4GALT4—prostate cancer	3.3e-06	3.64e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HPGD—prostate cancer	3.3e-06	3.64e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AKT1—prostate cancer	3.29e-06	3.62e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—prostate cancer	3.28e-06	3.61e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOA2—prostate cancer	3.2e-06	3.53e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NOS3—prostate cancer	3.15e-06	3.47e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	3.11e-06	3.42e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC5A5—prostate cancer	3.05e-06	3.37e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.02e-06	3.33e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTAP—prostate cancer	3.02e-06	3.33e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTEN—prostate cancer	3.02e-06	3.33e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP2E1—prostate cancer	2.98e-06	3.29e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NQO1—prostate cancer	2.95e-06	3.25e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SULT1E1—prostate cancer	2.94e-06	3.25e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SRD5A1—prostate cancer	2.94e-06	3.25e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TH—prostate cancer	2.91e-06	3.21e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CB—prostate cancer	2.91e-06	3.2e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—prostate cancer	2.88e-06	3.18e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—EP300—prostate cancer	2.88e-06	3.17e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP3A4—prostate cancer	2.88e-06	3.17e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTEN—prostate cancer	2.86e-06	3.15e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKT1—prostate cancer	2.85e-06	3.14e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1B1—prostate cancer	2.83e-06	3.12e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HSD17B3—prostate cancer	2.81e-06	3.1e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ACSL4—prostate cancer	2.81e-06	3.1e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GGT1—prostate cancer	2.74e-06	3.02e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—EP300—prostate cancer	2.73e-06	3.01e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOA1—prostate cancer	2.7e-06	2.98e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ARG2—prostate cancer	2.69e-06	2.97e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PHGDH—prostate cancer	2.69e-06	2.97e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—UMPS—prostate cancer	2.69e-06	2.97e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP19A1—prostate cancer	2.66e-06	2.93e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—LDHB—prostate cancer	2.64e-06	2.91e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.59e-06	2.86e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—RXRA—prostate cancer	2.57e-06	2.83e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTEN—prostate cancer	2.51e-06	2.77e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PDHA1—prostate cancer	2.5e-06	2.76e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TCN2—prostate cancer	2.5e-06	2.76e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—UCP3—prostate cancer	2.5e-06	2.76e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTA3—prostate cancer	2.5e-06	2.76e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—COMT—prostate cancer	2.47e-06	2.73e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTP1—prostate cancer	2.46e-06	2.71e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ITPR1—prostate cancer	2.42e-06	2.67e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—EP300—prostate cancer	2.4e-06	2.64e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.39e-06	2.63e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.39e-06	2.63e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.29e-06	2.52e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTA4—prostate cancer	2.29e-06	2.52e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TYMS—prostate cancer	2.29e-06	2.52e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTM1—prostate cancer	2.26e-06	2.49e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTA2—prostate cancer	2.23e-06	2.46e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—LPL—prostate cancer	2.22e-06	2.45e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCG5—prostate cancer	2.2e-06	2.43e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.2e-06	2.43e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTA1—prostate cancer	2.15e-06	2.37e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1A1—prostate cancer	2.14e-06	2.36e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CA—prostate cancer	2.13e-06	2.35e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.13e-06	2.35e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTO1—prostate cancer	2.13e-06	2.35e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NAT2—prostate cancer	2.13e-06	2.35e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ERCC2—prostate cancer	2.13e-06	2.34e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PLCB2—prostate cancer	2.04e-06	2.25e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.04e-06	2.25e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—LRP2—prostate cancer	2.04e-06	2.25e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CA—prostate cancer	2.02e-06	2.22e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—P4HB—prostate cancer	2e-06	2.21e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTHFR—prostate cancer	2e-06	2.2e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARA—prostate cancer	1.96e-06	2.16e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.95e-06	2.15e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.9e-06	2.09e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MED12—prostate cancer	1.87e-06	2.06e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GNG5—prostate cancer	1.85e-06	2.04e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CAV1—prostate cancer	1.84e-06	2.03e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOA3—prostate cancer	1.78e-06	1.97e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CA—prostate cancer	1.77e-06	1.95e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKT1—prostate cancer	1.74e-06	1.92e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HPGDS—prostate cancer	1.7e-06	1.88e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.69e-06	1.86e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.68e-06	1.85e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ACHE—prostate cancer	1.65e-06	1.82e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTT1—prostate cancer	1.65e-06	1.82e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKT1—prostate cancer	1.65e-06	1.82e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.63e-06	1.8e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—INS—prostate cancer	1.59e-06	1.75e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.59e-06	1.75e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PRKACB—prostate cancer	1.58e-06	1.74e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.56e-06	1.72e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CREBBP—prostate cancer	1.56e-06	1.72e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOA2—prostate cancer	1.49e-06	1.64e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.48e-06	1.63e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKT1—prostate cancer	1.45e-06	1.6e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.42e-06	1.57e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NOS3—prostate cancer	1.39e-06	1.54e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.39e-06	1.53e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NQO1—prostate cancer	1.37e-06	1.51e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TH—prostate cancer	1.35e-06	1.49e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.32e-06	1.45e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.29e-06	1.42e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—prostate cancer	1.27e-06	1.41e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GGT1—prostate cancer	1.27e-06	1.4e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.25e-06	1.38e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.24e-06	1.36e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—RXRA—prostate cancer	1.19e-06	1.32e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—COMT—prostate cancer	1.15e-06	1.27e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.14e-06	1.26e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.13e-06	1.24e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTEN—prostate cancer	1.11e-06	1.23e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TYMS—prostate cancer	1.06e-06	1.17e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—EP300—prostate cancer	1.06e-06	1.17e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.05e-06	1.16e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—LPL—prostate cancer	1.03e-06	1.14e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1A1—prostate cancer	9.97e-07	1.1e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ERCC2—prostate cancer	9.88e-07	1.09e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTHFR—prostate cancer	9.29e-07	1.02e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARA—prostate cancer	9.12e-07	1e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CAV1—prostate cancer	8.57e-07	9.45e-06	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CA—prostate cancer	7.84e-07	8.65e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.81e-07	8.61e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—INS—prostate cancer	7.39e-07	8.15e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CREBBP—prostate cancer	7.24e-07	7.98e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.86e-07	7.57e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NOS3—prostate cancer	6.48e-07	7.14e-06	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKT1—prostate cancer	6.41e-07	7.06e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.98e-07	6.59e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—prostate cancer	5.93e-07	6.53e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTEN—prostate cancer	5.17e-07	5.7e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—EP300—prostate cancer	4.93e-07	5.43e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.65e-07	4.02e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKT1—prostate cancer	2.98e-07	3.28e-06	CbGpPWpGaD
